+

WO1997030351A1 - Methode diagnostique pour mesurer le taux d'ammoniac dans l'haleine - Google Patents

Methode diagnostique pour mesurer le taux d'ammoniac dans l'haleine Download PDF

Info

Publication number
WO1997030351A1
WO1997030351A1 PCT/EP1997/000712 EP9700712W WO9730351A1 WO 1997030351 A1 WO1997030351 A1 WO 1997030351A1 EP 9700712 W EP9700712 W EP 9700712W WO 9730351 A1 WO9730351 A1 WO 9730351A1
Authority
WO
WIPO (PCT)
Prior art keywords
ammonia
acid
indicator system
captured
indicator
Prior art date
Application number
PCT/EP1997/000712
Other languages
English (en)
Inventor
Thomas John Baldwin
Saverio Peter Borriello
Helen Mary Palmer
Christopher Geoffrey Dominic Sykesud
Original Assignee
The Boots Company Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Boots Company Plc filed Critical The Boots Company Plc
Priority to AU17696/97A priority Critical patent/AU1769697A/en
Publication of WO1997030351A1 publication Critical patent/WO1997030351A1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/497—Physical analysis of biological material of gaseous biological material, e.g. breath
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
    • G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
    • G01N31/223—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators for investigating presence of specific gases or aerosols
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)

Definitions

  • This invention relates to the detection of ammonia in the breath of subjects, for example subjects suffering renal failure or Helicobacter pylori (H pylon) infections in the gastrointestinal tract.
  • H pylori infection is believed to be implicated in the development of gastritis, peptic ulceration and gastric cancer. Detection of the presence of H pylori infection would therefore enable those patients who are infected and who have, or are at risk of developing, symptoms of dyspesia, gastritis, peptic ulceration and gastric cancer to be identified so that approp ⁇ ate treatment can be given.
  • H pylon produces carbon dioxide and ammonia by the action of its urease on urea present in low levels in all body fluids.
  • One standard test to detect the carbon dioxide produced in this reaction involves the administration to the patient of an oral dose of C-isotopically-labelled urea followed by the measurement of the amount of labelled carbon dioxide exhaled in the breath of the patient by mass spectrometry or scintillation counting. This test is expensive and can only be performed under the supervision of medical practitioners where access to a mass spectrometer or scintillation counter is available.
  • the amount of ammonia produced in the stomach of patients infected with H pylon can be measured by taking a sample of the gastric juice by means of endoscopy. This is an invasive technique requiring the presence of skilled medical staff. Immunological tests exist to detect antibodies to H pylori in body fluids (eg blood or saliva). These tests can continue to give false positive results long after any H pylori infection has been eradicated.
  • the present invention provides a non-invasive, speedy and accurate means to detect the ammonia in the exhaled breath of the patient infected with H pylon
  • the test can be conducted by personnel with only a small amount of training or by the patient themselves
  • a first aspect of the present invention provides a method of detecting ammonia in the exhaled breath of a patient which method comprises capturing the ammonia present in the exhaled breath and contacting said captured ammonia with an indicator system which exhibits a detectable visible change in the presence of ammonia
  • a second aspect of the present invention provides a detection device for detecting ammonia in the exhaled breath of a patient, which device comprises a chamber in which are located means to capture the ammonia in the breath and means whereby the ammonia so captured can be contacted with an indicator system which exhibits a detectable change in the presence of ammonia and means whereby the exhaled breath of the patient is directed into the chamber
  • the ammonia may be captured by an indicator system which reacts directly with the ammonia to give a detectable visible change
  • the indicator system is incorporated into or is absorbed or coated onto a support.
  • the support may be porous and may comprise a fibrous material or a particulate material which may be sintered or in the form of beads. Suitable materials include porous cellulose materials (eg paper), nylon, nitrocellulose, zeolites, sintered solid materials such as calcium phosphate or a support in the form of beads for example of agarose or carageenan beads.
  • the indicator system may be incorporated into the porous support so that it is present uniformly throughout the support or it may be absorbed or coated onto the outer surfaces of the support.
  • the indicator system In the case of an indicator system uniformly dispersed through the porous support the indicator system will be incorporated into the support during the manufacturing process but in the case of an indicator which is absorbed or coated onto the surface the indicator will be absorbed or coated onto a preformed support which may be the interior surface of the tube into which the breath to be tested is exhaled.
  • the support should have a large surface area to maximise the contact between the exhaled ammonia and the indicator to ensure maximum sensitivity.
  • the indicator system may provide a qualitative test which indicates merely the presence or absence of ammonia in the exhaled breath or it may provide a quantitative test in which the amount of ammonia in the exhaled breath can be determined. Such a quantitative test may rely on an increase in the intensity of the colour change exhibited by the indicator system in the presence of increased amounts of ammonia to provide a determination of the amount of ammonia present.
  • an indicator system may be used which indicates the amount of ammonia present by the proportion of the support over which the indicated change has occurred in the presence of ammonia.
  • the indicator system must be one which detects only ammonia and is not influenced by the presence of any other compound which might be found in the exhaled breath of the patient so as to exclude the possibility of false positives
  • the indicator system should be one which undergoes a distinct colour change in the presence of ammonia so that a positive result can be determined by visual inspection only
  • other means for example electronic detectors, may be used to determine that the change indicating the presence of ammonia has occurred
  • the change produced must be stable for a sufficient period of time for the user to be able to detect the change and thus become aware of a positive test The longer the change remains apparent the more likely it is for the user to notice the change
  • the change should preferably be stable for at least one minute and preferably at least 5 minutes
  • the change occurs immediately the exhaled ammonia comes into contact with the indicator If there is a period of time after contact with the exhaled air during which the detectable change in the indicator develops, then the development must be uniform and consistent so that the user can be provided with detailed instructions on how
  • the indicator may contain one or more first or second series transition meta! ions from Groups IB, VIIB or VIIIB of the Periodic Table which indicate the presence of ammonia by means of complex formation between the transition metal ion and the exhaled ammonia
  • Complexes of transition metal ions can be highly coloured and can therefore form the basis of a direct indicator of the presence of ammonia
  • transition metal ions which can exist in more than one valency or oxidation state the ammonia may form a complex with the metal ion in one valency or oxidation state and that complex may be more susceptible to reduction or oxidation to another valency or oxidation state If the colour exhibited by the transition metal ion complex in the second valency or oxidation state differs from that of the original complex, a detectable colour change will be seen which indicates the presence of ammonia in the exhaled breath sample.
  • Suitable transition metal ions would include nickel [Ni(ll)], cobaltous [Co(ll)], ferrous [Fe(ll)], cuprous [Cu(ll)] and manganous [Mn(ll)].
  • the transition metal ions may be in the form of simple salts with counterions such as chloride or sulphate ions.
  • the salts should be soluble so that a solution can be used to impregnate or coat the indicator support.
  • the suitability of transition metal salts to be used as indicators can be demonstrated as follows. An aqueous ammonia solution was diluted until the concentration of ammonia was in the micromolar range. A fibrous support which had been immersed in an aqueous solution of the transition metal salt was then held above the diluted aqueous ammonia.
  • ferrous chloride and cobaltous chloride gave a colouration which developed in 2 to 4 minutes and achieved its maximum intensity after about 10 minutes. Observable colour changes were also detected with manganous chloride, cuprous chloride, cuprous sulphate and nickel chloride. Mixtures of transition metal ions may also be used.
  • the indicator system may comprise an acid/base indicator which is one colour at acid or neutral pH values but which changes to a different colour at higher pH values. Ammonia is believed to be the only basic gas present in breath which would cause such an indicator to change colour.
  • the acid/base indicator may be incorporated into or absorbed or coated onto a porous support of the type described hereinbefore. Suitable acid/base indicators include 4-nitrophenol, bromothymol blue and bromocresol purple.
  • the present invention may be performed in two distinct stages. In the first the ammonia is captured and then measured or detected by the indicator system in the second stage. For example the breath of the patient may be passed through an acidic medium into which the ammonia is absorbed by salt formation. The acidic medium can then be contacted with an indicator such as the transition metal ions listed above to provide a visible indication of the presence of ammonia. If the acidic capture conditions are not the most appropriate for the formation of the transition metal complexes then the pH of the system can be adjusted to give more favourable conditions for complex formation.
  • the acidic medium may be a dilute aqueous solution of an acid, for example hydrochloric, sulphuric, nitric or phosphoric acid or an organic acid, for example acetic, citric, tartaric or succinic acids or tungstic acid.
  • the acid may be absorbed or coated on to a porous support which may be a fibrous material eg paper, absorbent cellulose fibres, nylon or nitrocellulose or may be a particulate material eg zeolites, sintered solids or in the form of beads. Alternatively the acid may be absorbed onto a porous coating applied to a supporting member.
  • the acid may be absorbed onto a material which is coated onto the walls of the chamber in which the ammonia is captured or onto solid supports eg plates or beads contained in the chamber. It may be necessary to add water to the acid immediately prior to use to ensure that the acid efficiently captures the ammonia in the breath. Any water added must be purified to ensure that it does not contain any ammonia or other materials which could give rise to false results.
  • the captured ammonia may be detected by utilising the ammonia as a reactant in one stage of a multistage reaction which gives rise to a coloured end point.
  • suitable multistage reactions include the pyridine-pyrazoione reaction and the indophenol reaction both of which give a coloured material as their end point.
  • the pyridine-pyrazoione reaction has been described by Okita and Kanamori [Atmospheric Environment, Vol 5, 621-627 (1971)] and by Kruse and Mellon [Analytical Chemistry, Vol 25, 1188-1192 (1953)].
  • the aqueous sample is buffered to pH 3.7 with a sodium acetate/acetic acid buffer and then chloramine-T is added.
  • chloramine-T is added.
  • a pyridine-pyrazoione reagent is added and a purple colour develops if ammonia had been present in the sample.
  • the purple coloured species is soluble in tetrachioromethane and can be extracted into this solvent for quantitative analysis.
  • the indophenol reaction (also known as the Berthelot reaction) has been discussed by Liddicoat, Tibbitts and Butler (Limnol. Oceanogr., Vol 20, 131 -132 (1975)], by Patton and Crouch [Analytical Chemistry, Vol 49, 464-469 (1977)] and by Ngo, Phan, Yam and Lenhoff [Anal. Chem., Vol. 54, 46-49 (1982)].
  • the method involves the reaction of ammonia with hypochlorite ions to form monochloramine.
  • the chloramine then reacts with a phenolate anion in the presence of a catalyst and hydroxyl ions to give quinone chlorimide which then reacts with phenolate ion to give indophenol which is blue and the production of this blue colouration is indicative of the presence of ammonia in the breath sample.
  • the hypochlorite ions may be supplied by a solution of sodium hypochlorite in aqueous sodium hydroxide solution. Such solutions are available commercially but are known to be unstable. Solids which give hypochlorite ions on solution with water are known.
  • An example of a suitable material is sodium dichloroisocyanurate.
  • the phenolate anion may be derived from phenol itself or may be derived from any substituted phenol which is capable of undergoing the reaction described above to give a coloured substituted indophenol. Suitable substituted phenols include 2-chlorophenol,
  • Suitable catalysts include sodium nitroprusside, potassium ferrocyanide, manganous ions or acetone.
  • Figure 1 is a schematic cross-sectional representation of a first embodiment of the invention.
  • Figure 2 is a schematic cross-sectional representation of a second embodiment of the invention.
  • Figure 3 is a schematic cross-sectional representation of a third embodiment of the invention.
  • Figure 4 is a schematic cross-sectional representation of the embodiment shown in Figure 3 during the analysis phase.
  • Figure 5 is a schematic cross-sectional representation of a fourth embodiment of the invention.
  • Figure 1 shows a detection device having a tube 1 closed at one end having a mouthpiece 2 which may incorporate a non-return valve (not shown) and which may be integrally formed with the tube I or may be removably attached to it.
  • a side tube 3 passes from the interior of the tube 1 to the interior of a collection chamber 4.
  • the collection chamber 4 has an exhaust tube 5 which is either open to the atmosphere or is attached to gas-volume measuring means (not shown).
  • the collection chamber is closed by a cover 6.
  • the side tube 3 may be provided with coupling means (not shown) to enable the collection chamber 4 together with the cover 6 and the tubes 3, 5 to be separated from the tube 1.
  • the medium may be a solution of a weak acid (eg phosphoric acid) or may be a support (eg beads or a gel) coated with an acidic ammonia-absorbing reagent.
  • the exhaled breath which has been scrubbed of its ammonia passes out of the chamber 4 through the exhaust tube 5.
  • the exhaust tube 5 may be attached to a balloon which is inflated as the subject exhales.
  • the predetermined volume of exhaled breath may be determined by means of a piston which moves within a tube by a set distance or the breath may be split between the tube 1 and a second tube (not shown) containing a measuring system which reacts to the presence of carbon dioxide or moisture in the exhaled breath (eg cobaltous chloride impregated onto silica gel).
  • a measuring system which reacts to the presence of carbon dioxide or moisture in the exhaled breath (eg cobaltous chloride impregated onto silica gel).
  • the ammonia may be detected by any of the methods described above. For example, solutions of phenol and alkaline hypochlorite may be added to initiate the indophenol reaction. The detection of the ammonia may be performed immediately or the chamber 4 may be sealed and its contents assayed later.
  • FIG. 2 shows a second embodiment of the present invention comprising a tube 11 containing an absorbent porous mass (shown schematically as 12) which is treated with an acidic medium into which the ammonia from the exhaled breath of a subject is captured.
  • the porous mass 12 may act as a support for a liquid acidic medium coated or absorbed thereon.
  • the caps 13, 14 will prevent the porous mass drying out prior to use.
  • the porous mass may support a solid acidic material which is activated immediately prior to use by the addition of a measured amount of water to the tube 11. In this case the caps 13, 14 sealing the tube 11 will prevent premature activation by atmospheric moisture.
  • a mouthpiece 15 is fitted and the patient exhales through the tube 11
  • the end cap 13 is removed and a specified volume of water added The cap 13 is replaced and the tube shaken until the porous mass has taken up the water activating the previously dry acidic medium Both end caps 13, 14 are then removed and the mouthpiece 15 fitted to enable the subject to exhale through the tube 11
  • Means such as those described above may be attached to the end of the tube 11 remote from the mouthpiece to ensure that a predetermined volume of exhaled air passes through the porous mass 12
  • the tube may then be sealed and the assay of the ammonia captured in it may be performed later Alternatively one end of the tube may be reclosed by replacing the cap on it and the remaining parts of the indicator system may be added for immediate detection of the ammonia
  • solutions of phenol, alkaline hypochlorite and catalyst may be added to initiate the indophenol reaction
  • the porous mass 12 contains a solid acid and the indicator eg a transition metal indicator system as described above in anhydrous form The acid and indicator are activated immediately prior to use by the addition of water
  • the porous mass 12 contains a dry acid and the components of the indicator system (the phenol, a solid source of hypochlorite ion eg sodium dichloroisocyanurate and the catalyst eg potassium ferrocyanide) encapsulated in a water-soluble coating which dissolves slowly in the presence of water to release the components.
  • the components may be encapsulated separately or may be encapsulated together if the mixed components in the dry state would have a satisfactory shelf-life prior to use. immediately prior to use a specified amount of water is added which immediately activates the acidic capture medium and slowly releases the reagents for the indophenol reaction.
  • the ammonia in the subject's exhaled breath will then be captured by the immediately-activated acidic medium and subsequently the components needed to initiate the indophenol reaction will become available.
  • the water needed to activate the device may be added from an external source or may be contained within the device but kept separate from the porous mass 12 prior to use. The water may be contained in a closed rupturable container held within the tube 11 (not shown).
  • the embodiment shown in Figures 3 and 4 comprise a tube 21 which is open at both ends and which contains a porous mass 22 in which is located an acidic medium to absorb the ammonia and at least part of the indicator system.
  • a mouthpiece 23 can be fitted to enable the subject to exhale into the tube.
  • the end of the tube remote from the mouthpiece is fitted with a porous plug 23.
  • a container 25 contains a solution of the remaining parts of the indicator system.
  • the container 25 has an opening in one wall thereof into which the end of the tube 21 containing the porous plug 23 may be inserted.
  • the tube 21 When the tube is inserted into the opening, resilient seals 26 around the opening grip the outside of the tube 21. Prior to use the opening is sealed by a membrane 27 to prevent the egress of liquid. However, as the container 25 is pushed on to the end of the tube 21 as shown in Figure 4, the end of the tube is pushed against the membrane 27 causing it to rupture to release the contents of the container 25 into the tube 21 The liquid contents of the container 25 pass through the porous plug 23 and contact the materials inside the porous mass 22 If the indophenol reaction is being used to detect the presence of ammonia, the porous mass 23 may contain the phenol and the catalyst and the container 25 may contain an aqueous solution of alkaline hypochlorite As the alkaline hypochlorite enters the porous mass it neutralises the acid and dissolves the phenol and catalyst which are required to initiate the indophenol reaction The ends of the tube 21 should be shaped so as to prevent the inadvertent fitting of the container 25 or the base 24 to the wrong end of the tube
  • Figure 5 shows a further embodiment of the present invention which comprises a tube 31 containing a porous filling 32 onto which an acidic ammonia-absorbing reagent and a part of the indicator system are absorbed or coated
  • the outer surface of the tube 31 has a plurality of radial ribs 33.
  • One end of the tube is closed by a non-return valve 34.
  • This one end of the tube may be formed into the shape of a mouthpiece or may be adapted to interengage with a separate mouthpiece (not shown)
  • the one end of the tube is surrounded by a hemispherical sleeve 35 the outer edge 36 of which extends at least as far as the one end of the tube.
  • the sleeve 35 Prior to use the sleeve 35 may be sealed by means of a removeable film (not shown) sealed to its outer edge 36
  • the other end of the tube carries a cap 37
  • the cap 37 is rotatable from a first position to a second position.
  • the outer surface of the cap 37 is provided with radial grooves (not shown) which are not aligned with the ribs 33 in the first position but which are aligned with the ribs 33 in the second position enabling the cap 37 to be moved towards the mouthpiece end of the tube 31
  • the cap encloses a chamber 38 which when the cap is in its first position is sealed with a foil 39.
  • the chamber 38 contains the remaining part of the indicator system in liquid form
  • the cap has one or more outlet apertures 40 through which the exhaled air which has passed along the tube 31 is vented to the atmosphere. Prior to use the outlet apertures 40 may be sealed by a removeable seal.
  • An inner piercing tube 41 extends from the end of the tube 31 remote from the mouthpiece towards the foil 39 sealing the chamber 38.
  • the inner end of the piercing tube is supported coaxially within the end of the tube 31 by an apertured plate (not shown) or radial ribs (not shown) joining the interior wall of the tube 31 to the outer wall of the piercing tube 41.
  • the apertures or the space between the ribs must have a sufficiently large area that the flow of exhaled air is not unduly hindered.
  • the outer end of the piercing tube 41 may be shaped to ensure that the tube can pierce the seal 39.
  • the seal over the outlet apertures 40 and, if present the seal on the outer end of the sleeve 35, is removed.
  • the subject then exhales through the tube 31.
  • the ammonia is captured by the ammonia-absorbing reagent in the filling 32 and the exhaled breath passes through the aperture(s) 40.
  • the device is then stood upright on the outer edge 36 of the sleeve 35.
  • the cap 37 is then rotated until the ribs 33 on the tube 31 are aligned with the grooves on the cap 37.
  • the cap 37 is then pushed towards the mouthpiece.
  • the grooves move over the ribs 33.
  • the outer end of the piercing tube 41 pierces the seal 39 and the contents of the chamber flow into the interior of the tube 31 through the piercing tube 41.
  • the indicator system is based on the indophenol reaction
  • the phenol and the catalyst may be absorbed or coated onto the filling 32 and the liquid in the chamber 38 may be an alkaline solution of hypochlorite .
  • the test may be conducted on patients first thing in the morning before they have ingested any food or drink which might contain sources of ammonia or urease. Foods which contain sources of ammonia or ureases which could mimic H pylori urease (for example pineapple), would have to be avoided by the patient. If the amount of urea present in the gastric environment is insufficient the patient could be predosed with a known amount of urea or other suitable material to provide more substrate on which the H pylori urease can act resulting in more detectable ammonia in the exhaled breath of the patient.
  • the urea or other substrate for the H pylori urease may be given in a capsule or a coated tablet to minimise dry interaction with urease-containing bacterial plaque in the oral cavity.
  • a period of time for example 30 minutes
  • ureases may be present in the oral cavity and these, if present, could react with urea to give ammonia. It may therefore be preferable for the patient to cleanse the oral cavity by the use of a toothbrush or mouthwash before the test is administered. Any dentifrice or mouthwash used must not contain any ingredients which might interfere with the test.
  • the subject was asked to exhale into a 100 ml glass syringe.
  • the piston of the syringe was forced beyond the 100 ml mark.
  • the piston was then pushed back to the 100 ml mark and 0.04N phosphoric acid (5 ml) was injected into the syringe.
  • the syringe was then sealed, shaken and stood at ambient temperature for 90 minutes.
  • the contents of the syringe were transferred to a 25 ml conical flask and 5 ml of each of Solution A and Solution B were added The mixture was placed in a microwave oven and heated on full power for 35 seconds If the breath sample contained ammonia then a blue colouration develops The intensity of the colour is dependent on the amount of ammonia and a quantitative determination of the amount can be obtained spectrophotometrically at 635 nm.
  • test is therefore capable of distinguishing subjects who are infected with H pylon from those who are not This would enable it to be used to screen patients for the presence of infection or to check that the prescribed drug regime had resulted in the eradication of the infection Unlike immunological tests, the test according to the present invention can be used soon after the drug treatment as, in the absence of H pylori infection, no ammonia will be generated from urea in the stomach.
  • the patient may be prescribed a drug regime to eliminate the infection or may be referred for further medical diagnosis by, for example, more detailed instrumental analysis of breath (eg a standard test such as the C-13 labelled urea breath test) or body fluids (eg an immunological assay) or endoscopy

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

On détecte l'ammoniac dans l'haleine de sujets humains, par exemple de sujets souffrant d'une infection à H. pylori, en capturant l'ammoniac et en le mettant en contact avec un système indicateur qui présente une modification visible détectable en présence d'ammoniac. Celui-ci peut être capturé dans un milieu acide. Le système indicateur peut réagir directement avec l'ammoniac; il peut contenir par exemple des ions métalliques de transition qui forment des complexes colorés avec l'ammoniac, ou bien un indicateur de pH. La capture de l'ammoniac et la mise en contact de ce dernier avec le système indicateur peuvent également se faire en deux étapes distinctes. Dans ce cas, le système indicateur peut être basé sur les réactions pyridine-pyrazolone ou indophénol.
PCT/EP1997/000712 1996-02-14 1997-02-13 Methode diagnostique pour mesurer le taux d'ammoniac dans l'haleine WO1997030351A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU17696/97A AU1769697A (en) 1996-02-14 1997-02-13 Diagnostic method for measuring the ammonia content in breath

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9603031.7A GB9603031D0 (en) 1996-02-14 1996-02-14 Diagnostic method
GB9603031.7 1996-02-14

Publications (1)

Publication Number Publication Date
WO1997030351A1 true WO1997030351A1 (fr) 1997-08-21

Family

ID=10788691

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1997/000712 WO1997030351A1 (fr) 1996-02-14 1997-02-13 Methode diagnostique pour mesurer le taux d'ammoniac dans l'haleine

Country Status (4)

Country Link
AU (1) AU1769697A (fr)
GB (1) GB9603031D0 (fr)
WO (1) WO1997030351A1 (fr)
ZA (1) ZA971263B (fr)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999051769A1 (fr) * 1998-04-03 1999-10-14 Lee Jong Hwa Composition, kit et procede de detection d'helicobacter pylori lors d'une biopsie
US6509169B2 (en) 2000-07-14 2003-01-21 University Of West England, Bristol Detection of Helicobacter pylori
WO2004006766A2 (fr) 2002-07-12 2004-01-22 Baxter International Inc. Procede et appareil permettant de deceler la presence d'une bacterie dans le tractus gastro-intestinal d'un sujet
WO2005059162A3 (fr) * 2003-12-16 2005-09-15 Kimberly Clark Co Detection et quantification microbienne
GB2416589A (en) * 2004-07-27 2006-02-01 Sensam Ltd Gas sampling device
US7014612B2 (en) * 2001-11-13 2006-03-21 Photonic Biosystems, Inc. Method for diagnosis of helicobacter pylori infection
WO2006097481A1 (fr) * 2005-03-16 2006-09-21 BAM Bundesanstalt für Materialforschung und -prüfung Membrane de capteur optochimique et procede de fabrication
WO2008081398A1 (fr) * 2006-12-29 2008-07-10 Universidade De Aveiro Procédé pour la détection de helicobacter pylori au moyen d'amides aliphatiques
US7582485B2 (en) * 2003-10-16 2009-09-01 Kimberly-Clark Worldride, Inc. Method and device for detecting ammonia odors and helicobacter pylori urease infection
US7727513B2 (en) 2005-12-15 2010-06-01 Kimberly-Clark Worldwide, Inc. Method for screening for bacterial conjunctivitis
CN105891405A (zh) * 2016-03-30 2016-08-24 深圳三相生物传感科技有限公司 一种用于诊断人体幽门螺杆菌感染的装置及检测人体呼气中氨气含量的方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109655478B (zh) * 2018-12-12 2024-02-27 深圳市福瑞康科技有限公司 一种闪烁检测装置

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53110892A (en) * 1977-03-10 1978-09-27 Osaka Gas Co Ltd Reagent for measuring ammonia concentration
JPS5619452A (en) * 1979-07-27 1981-02-24 Yatoron:Kk Measuring method for ammonia in liquid
US4947861A (en) * 1989-05-01 1990-08-14 Hamilton Lyle H Noninvasive diagnosis of gastritis and duodenitis
WO1991007659A1 (fr) * 1989-11-08 1991-05-30 British Technology Group Ltd. Detecteurs de gaz et composes utilisables a cet effet
WO1991019192A1 (fr) * 1990-06-06 1991-12-12 Mallow William A Composition et procede de detection de reactifs sous forme de vapeur et de liquide
US5364797A (en) * 1993-05-20 1994-11-15 Mobil Oil Corp. Sensor device containing mesoporous crystalline material
EP0679721A1 (fr) * 1994-04-27 1995-11-02 Gastec Corporation Procédé simple d'examen d'une infection dûe à helicobacter pylori et dispositif pour sa mise en oeuvre

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53110892A (en) * 1977-03-10 1978-09-27 Osaka Gas Co Ltd Reagent for measuring ammonia concentration
JPS5619452A (en) * 1979-07-27 1981-02-24 Yatoron:Kk Measuring method for ammonia in liquid
US4947861A (en) * 1989-05-01 1990-08-14 Hamilton Lyle H Noninvasive diagnosis of gastritis and duodenitis
WO1991007659A1 (fr) * 1989-11-08 1991-05-30 British Technology Group Ltd. Detecteurs de gaz et composes utilisables a cet effet
WO1991019192A1 (fr) * 1990-06-06 1991-12-12 Mallow William A Composition et procede de detection de reactifs sous forme de vapeur et de liquide
US5364797A (en) * 1993-05-20 1994-11-15 Mobil Oil Corp. Sensor device containing mesoporous crystalline material
EP0679721A1 (fr) * 1994-04-27 1995-11-02 Gastec Corporation Procédé simple d'examen d'une infection dûe à helicobacter pylori et dispositif pour sa mise en oeuvre

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 7844, Derwent World Patents Index; AN 78-79062A [44], XP002030256 *
PATENT ABSTRACTS OF JAPAN vol. 5, no. 69 (P - 060) 9 May 1981 (1981-05-09) *

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187556B1 (en) 1998-04-03 2001-02-13 Jong-Hwa Lee Composition, kit, and method for detecting Helicobacter pylori in biopsy
WO1999051769A1 (fr) * 1998-04-03 1999-10-14 Lee Jong Hwa Composition, kit et procede de detection d'helicobacter pylori lors d'une biopsie
US6509169B2 (en) 2000-07-14 2003-01-21 University Of West England, Bristol Detection of Helicobacter pylori
US7014612B2 (en) * 2001-11-13 2006-03-21 Photonic Biosystems, Inc. Method for diagnosis of helicobacter pylori infection
WO2004006766A2 (fr) 2002-07-12 2004-01-22 Baxter International Inc. Procede et appareil permettant de deceler la presence d'une bacterie dans le tractus gastro-intestinal d'un sujet
WO2004006766A3 (fr) * 2002-07-12 2004-05-06 Baxter Int Procede et appareil permettant de deceler la presence d'une bacterie dans le tractus gastro-intestinal d'un sujet
US7582485B2 (en) * 2003-10-16 2009-09-01 Kimberly-Clark Worldride, Inc. Method and device for detecting ammonia odors and helicobacter pylori urease infection
US7282349B2 (en) 2003-12-16 2007-10-16 Kimberly-Clark Worldwide, Inc. Solvatochromatic bacterial detection
WO2005059162A3 (fr) * 2003-12-16 2005-09-15 Kimberly Clark Co Detection et quantification microbienne
GB2416589A (en) * 2004-07-27 2006-02-01 Sensam Ltd Gas sampling device
WO2006097481A1 (fr) * 2005-03-16 2006-09-21 BAM Bundesanstalt für Materialforschung und -prüfung Membrane de capteur optochimique et procede de fabrication
US7727513B2 (en) 2005-12-15 2010-06-01 Kimberly-Clark Worldwide, Inc. Method for screening for bacterial conjunctivitis
WO2008081398A1 (fr) * 2006-12-29 2008-07-10 Universidade De Aveiro Procédé pour la détection de helicobacter pylori au moyen d'amides aliphatiques
CN105891405A (zh) * 2016-03-30 2016-08-24 深圳三相生物传感科技有限公司 一种用于诊断人体幽门螺杆菌感染的装置及检测人体呼气中氨气含量的方法

Also Published As

Publication number Publication date
ZA971263B (en) 1998-04-16
GB9603031D0 (en) 1996-04-10
AU1769697A (en) 1997-09-02

Similar Documents

Publication Publication Date Title
AU672823B2 (en) Oral collection device and kit
US5339829A (en) Oral collection device
US4434235A (en) Method and apparatus for detecting nitrite ions in fluids
US5834626A (en) Colorimetric indicators for breath, air, gas and vapor analyses and method of manufacture
US4970172A (en) Method and device for ketone measurements
US7014612B2 (en) Method for diagnosis of helicobacter pylori infection
EP2684025B1 (fr) Détecteur de cétones dans l'haleine
EP1898787B1 (fr) Appareil d'echantillonnage d'haleine
WO1997030351A1 (fr) Methode diagnostique pour mesurer le taux d'ammoniac dans l'haleine
EP0881491A1 (fr) PROCEDE ET KIT DE DETECTION DE $i(HELICOBACTER PYLORI)
US5166075A (en) Method for determining whether respiratory gas is present in a gaseous sample
EP0279069A2 (fr) Procédé et dispositif pour mesurer les cétones
EP0257916B1 (fr) Dispositif indicateur
US20030195435A1 (en) Method and apparatus for collecting and transporting capillary blood samples for diagnostic and research evaluation
US20010021815A1 (en) Breath test analyzer
US20020015663A1 (en) Oral collection device and kit
US20050171449A1 (en) Method and apparatus for detecting ammonia from exhaled breath
US20020090667A1 (en) Detection of Helicobacter Pylori
CN100514043C (zh) 尿液碘测定试剂盒
JP2010131011A (ja) ヘリコバクター・ピロリ菌のテストストリップ及び検出方法
US3676072A (en) Breath test for marijuana smokers and apparatus therefor
US5552324A (en) Method and apparatus for determining the concentration of readily oxidizable organic vapors in gas samples
US3420224A (en) Apparatus for analysis of respired gas
WO2002006822A1 (fr) Procede de detection d'helicobacter pylori et appareil associe
US4956300A (en) Aid for determining the presence of occult blood, method of making the aid, and method of using the aid

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97528996

Format of ref document f/p: F

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载